Pilar Blanco-Lobo
University of Rochester
Live attenuated influenza vaccineVirologyVaccinationVirusInfluenza A virus
What is this?
Publications 4
#1Luis Martínez-Sobrido (UR: University of Rochester)H-Index: 42
#2Pilar Blanco-Lobo (UR: University of Rochester)
Last. Aitor Nogales (UR: University of Rochester)H-Index: 17
view all 84 authors...
The continual emergence of novel influenza A strains from non-human hosts requires constant vigilance and the need for ongoing research to identify strains that may pose a human public health risk. Since 1999, canine H3 influenza A viruses (CIVs) have caused many thousands or millions of respiratory infections in dogs in the United States. While no human infections with CIVs have been reported to date, these viruses could pose a zoonotic risk. In these studies, the National Institutes of Allergy...
1 CitationsSource
#1Pilar Blanco-Lobo (UR: University of Rochester)H-Index: 2
#2Laura Rodriguez (UR: University of Rochester)H-Index: 8
Last. Luis Martínez-Sobrido (UR: University of Rochester)H-Index: 42
view all 8 authors...
Vaccination remains the most effective approach for preventing and controlling equine influenza virus (EIV) in horses. However, the ongoing evolution of EIV has increased the genetic and antigenic differences between currently available vaccines and circulating strains, resulting in suboptimal vaccine efficacy. As recommended by the World Organization for Animal Health (OIE), the inclusion of representative strains from clade 1 and clade 2 Florida sublineages of EIV in vaccines may maximize the ...
#1Laura Rodriguez (UR: University of Rochester)H-Index: 8
#2Pilar Blanco-Lobo (UR: University of Rochester)H-Index: 2
Last. Luis Martínez-Sobrido (UR: University of Rochester)H-Index: 42
view all 10 authors...
Influenza viruses cause annual, seasonal infection across the globe. Vaccination represents the most effective strategy to prevent such infections and/or to reduce viral disease. Two major types of influenza vaccines are approved for human use: inactivated influenza vaccines (IIVs) and live attenuated influenza vaccines (LAIVs). Two Master Donor Virus (MDV) backbones have been used to create LAIVs against influenza A virus (IAV): the United States (US) A/Ann Arbor/6/60 (AA) and the Russian A/Len...
2 CitationsSource
#1Pilar Blanco-LoboH-Index: 2
#2Aitor NogalesH-Index: 17
Last. Luis Martínez-SobridoH-Index: 42
view all 4 authors...
Influenza virus still represents a considerable threat to global public health, despite the advances in the development and wide use of influenza vaccines. Vaccination with traditional inactivate influenza vaccines (IIV) or live-attenuated influenza vaccines (LAIV) remains the main strategy in the control of annual seasonal epidemics, but it does not offer protection against new influenza viruses with pandemic potential, those that have shifted. Moreover, the continual antigenic drift of seasona...
2 CitationsSource